Obes Surg 31:42164218 Suliman M et al (2019) Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients
BED is considered moderate if you have four to seven episodes of binge eating per week
37 These differences were explained with the lack of adequate up-titration of liraglutide in real-world setting, where less than 20% of subjects achieved the full 1.8 mg dosage as compared to the 100% that is mandatory in RCTs (AWARD-6)
Ultimately, the safety data is limited, and we dont have good evidence for how the peptide affects women in midlifea chapter when complex physiological changes are already underway
It is about blood pressure, blood sugar, cholesterol, fatty liver, sleep apnea, mobility, cardiovascular risk, and quality of life
In our first blog, we reviewed the defining themes of 2025 and explored macro and policy issues shaping the year ahead